Controlled release drug delivery offers significant market opportunities by optimizing therapeutic effects and patient adherence for chronic conditions such as diabetes, cancer, and cardiovascular ...
The review highlights nanocarriers, microspheres, hydrogels, microneedles, long-acting formulations, and co-formulations as ...
Controlled drug delivery systems based on in situ forming implants offer a versatile platform for achieving sustained and localised therapeutic release from a single administration. These systems ...
A recent study published in Nature Communications showcased a breakthrough in transdermal drug delivery. Scientists have developed an electrically activated patch with biocompatible metallic membranes ...
Potent drugs like chemotherapy can be life-saving, but often with life-threatening side effects. Notably, they can be ...
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...
The shift toward patient-centric healthcare and self-administration technologies is driving significant growth, but ...
U.S. market projected to grow from USD 2.45 billion in 2025 to USD 5.01 billion by 2035, while Europe is forecast to reach USD 4.02 billion amid rising adoption of transdermal therapeutics and vaccine ...
Lung cancer remains one of the world's deadliest cancers, yet despite decades of effort to develop new drugs, many fail ...
First and only commercially available AID technology for pregnancy use in the U.S. Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today ...
AUSTIN, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results